×
For best experience we recommend to activate Javascript in your browser.
CEACAM8 antibody (AA 35-320)
The Rabbit Polyclonal anti-CEACAM8 antibody has been validated for WB, ELISA and IHC. It is suitable to detect CEACAM8 in samples from Human.
Quick Overview for CEACAM8 antibody (AA 35-320) (ABIN7568445)
Target
See all CEACAM8 Antibodies
CEACAM8
(Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8 (CEACAM8))
Reactivity
All reactivities for CEACAM8 antibodies
Human
Host
All hosts for CEACAM8 antibodies
Rabbit
Clonality
All clonalities for CEACAM8 antibodies
Polyclonal
Conjugate
All conjugates for CEACAM8 antibodies
This CEACAM8 antibody is un-conjugated
Application
All applications for CEACAM8 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-CEACAM8 Antibody
(hide)
Binding Specificity
All epitopes for CEACAM8 antibodies
AA 35-320
Purpose
Anti-CD66b/CEACAM8 Polyclonal antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human CD66b / CEACAM8 (Gln35-Asp320).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for CEACAM8
(hide)
Target
CEACAM8
(Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8 (CEACAM8))
Alternative Name
CD66b
Background
CD67 antigen,Carcinoembryonic antigen CGM6,Carcinoembryonic antigen-related cell adhesion molecule 8,CGM6,CD66b,Non-specific cross-reacting antigen NCA-95,CEACAM8,
UniProt
P31997
Recently viewed
(hide)
Chat with us , powered by LiveChat